Two Sigma Advisers’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$104K Buy
15,732
+3,700
+31% +$24.5K ﹤0.01% 2204
2025
Q1
$110K Sell
12,032
-400
-3% -$3.66K ﹤0.01% 2230
2024
Q4
$131K Sell
12,432
-1,000
-7% -$10.5K ﹤0.01% 2186
2024
Q3
$161K Sell
13,432
-78,100
-85% -$933K ﹤0.01% 2112
2024
Q2
$526K Sell
91,532
-49,700
-35% -$286K ﹤0.01% 1858
2024
Q1
$734K Buy
141,232
+13,300
+10% +$69.2K ﹤0.01% 1713
2023
Q4
$674K Buy
127,932
+78,400
+158% +$413K ﹤0.01% 1804
2023
Q3
$163K Buy
49,532
+27,500
+125% +$90.8K ﹤0.01% 2135
2023
Q2
$63.7K Sell
22,032
-12,400
-36% -$35.8K ﹤0.01% 2249
2023
Q1
$36.8K Buy
+34,432
New +$36.8K ﹤0.01% 2479
2022
Q3
Sell
-10,132
Closed -$69K 2562
2022
Q2
$69K Sell
10,132
-700
-6% -$4.77K ﹤0.01% 2440
2022
Q1
$153K Sell
10,832
-2,197
-17% -$31K ﹤0.01% 2427
2021
Q4
$189K Sell
13,029
-16,171
-55% -$235K ﹤0.01% 2299
2021
Q3
$413K Buy
29,200
+19,200
+192% +$272K ﹤0.01% 1999
2021
Q2
$176K Buy
+10,000
New +$176K ﹤0.01% 2284